Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 60 results.
User Information
Export Records
  1. 1.   Neutral sphingomyelinase 2 is required for HIV-1 maturation
  2. Waheed, Abdul A; Zhu, Yanan; Agostino, Eva; Naing, Lwar; Hikichi, Yuta; Soheilian,Ferri; Yoo, Seung-Wan; Song, Yun; Zhang, Peijun; Slusher, Barbara S; Haughey, Norman J; Freed, Eric O
  3. Proceedings of the National Academy of Sciences of the United States of America. 2023, Jul 11; 120(28): e2219475120.
  1. 2.   Enhanced Transmissibility and Decreased Virulence of HIV-1 CRF07_BC May Explain Its Rapid Expansion in China
  2. Cheng, Zetao; Yan, Huanchang; Li, Qingmei; Ablan,Sherimay; Kleinpeter,Alex; Freed,Eric; Wu, Hao; Dzakah, Emmanuel Enoch; Zhao, Jianhui; Han, Zhigang; Wang, Haiying; Tang, Shixing
  3. Microbiology Spectrum. 2022, Jun 21; e0014622.
  1. 3.   INSTIs and NNRTIs Potently Inhibit HIV-1 Polypurine Tract Mutants in a Single Round Infection Assay
  2. Smith, Steven J; Ferris,Andrea; Zhao, Xuezhi; Pauly,Gary; Schneider,Joel; Burke,Terrence; Hughes,Stephen
  3. Viruses. 2021, Dec 14; 13(12):
  1. 4.   Effect of P-body component Mov10 on HCV virus production and infectivity
  2. Liu, Dandan; Ndongwe, Tanyaradzwa P; Puray-Chavez, Maritza; Casey, Mary C; Izumi, Taisuke; Pathak,Vinay; Tedbury, Philip R; Sarafianos, Stefan G
  3. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2020, Jun 04;
  1. 5.   The autophagy protein ATG9A promotes HIV-1 infectivity
  2. Mailler, Elodie; Waheed,Abdul; Park, Sang-Yoon; Gershlick, David C; Freed,Eric; Bonifacino, Juan S
  3. Retrovirology. 2019, Jul 03; 16(1): 18.
  1. 6.   Efficacies of Cabotegravir and Bictegravir against drug-resistant HIV-1 integrase mutants
  2. Smith, Steven; Zhao, Xue Zhi; Burke, Terrence; Hughes, Stephen
  3. Retrovirology. 2018, May 16; 15(1): 37.
  1. 7.   Functional Interplay Between Murine Leukemia Virus Glycogag, Serinc5, and Surface Glycoprotein Governs Virus Entry, with Opposite Effects on Gammaretroviral and Ebolavirus Glycoproteins
  2. Ahi, Yadvinder; Zhang, Shu; Thappeta, Yashna; Denman, Audrey; Feizpour, Amin; Gummuluru, Suryaram; Reinhard, Bjoern; Muriaux, Delphine; Fivash, Matt; Rein, Alan
  3. MBIO. 2016, Nov 22; 7(6): e01985.
  1. 8.   Three-Dimensional Structures of Soluble CD4-Bound States of Trimeric Simian Immunodeficiency Virus Envelope Glycoproteins Determined by Using Cryo-Electron Tomography
  2. White, T. A.; Bartesaghi, A.; Borgnia, M. J.; de la Cruz, M. J. V.; Nandwani, R.; Hoxie, J. A.; Bess, J. W.; Lifson, J. D.; Milne, J. L. S.; Subramaniam, S.
  3. Journal of Virology. 2011, Dec; 85(23): 12114-12123.
  1. 9.   Identification of Specific Determinants of Human APOBEC3F, APOBEC3C, and APOBEC3DE and African Green Monkey APOBEC3F That Interact with HIV-1 Vif
  2. Smith, J. L.; Pathak, V. K.
  3. Journal of Virology. 2010, Dec; 84(24): 12599-12608.
  1. 10.   Vif of Feline Immunodeficiency Virus from Domestic Cats Protects against APOBEC3 Restriction Factors from Many Felids
  2. Zielonka, J.; Marino, D.; Hofmann, H.; Yuhki, N.; Lochelt, M.; Munk, C.
  3. Journal of Virology. 2010, Jul; 84(14): 7312-7324.
  1. 11.   Multiple ways of targeting APOBEC3-virion infectivity factor interactions for anti-HIV-1 drug development
  2. Smith, J. L.; Bu, W.; Burdick, R. C.; Pathak, V. K.
  3. Trends in Pharmacological Sciences. 2009, Dec; 30(12): 638-646.
  1. 12.   HIV-1 and microvesicles from T cells share a common glycome, arguing for a common origin
  2. Krishnamoorthy, L.; Bess, J. W.; Preston, A. B.; Nagashima, K.; Mahal, L. K.
  3. Nature Chemical Biology. 2009 5(4): 244-250.
  1. 13.   The Nucleocapsid Region of Human Immunodeficiency Virus Type 1 Gag Assists in the Coordination of Assembly and Gag Processing: Role for RNA-Gag Binding in the Early Stages of Assembly
  2. Ott, D. E.; Coren, L. V.; Shatzer, T.
  3. Journal of Virology. 2009 83(15): 7718-7727.
  1. 14.   Dissecting APOBEC3G Substrate Specificity by Nucleoside Analog Interference
  2. Rausch, J. W.; Chelico, L.; Goodman, M. F.; Le Grice, S.
  3. Journal of Biological Chemistry. 2009 284(11): 7047-7058.
  1. 15.   APOBEC3G induces a hypermutation gradient: purifying selection at multiple steps during HIV-1 replication results in levels of G-to-A mutations that are high in DNA, intermediate in cellular viral RNA, and low in virion RNA
  2. Russell, R. A.; Moore, M. D.; Hu, W. S.; Pathak, V. K.
  3. Retrovirology. 2009 6: 16.
  1. 16.   Distinct Domains within APOBEC3G and APOBEC3F Interact with Separate Regions of Human Immunodeficiency Virus Type 1 Vif
  2. Russell, R. A.; Smith, J.; Barr, R.; Bhattacharyya, D.; Pathak, V. K.
  3. Journal of Virology. 2009 83(4): 1992-2003.
  1. 17.   Fusion inhibitor prevents spread of immunodeficiency viruses, but not activation of virus-specific T cells, by dendritic cells
  2. Frank, I.; Stossel, H.; Gettie, A.; Turville, S. G.; Bess, J. W.; Lifson, J. D.; Sivin, I.; Romani, N.; Robbiani, M.
  3. Journal of Virology. 2008 82(11): 5329-5339.
  1. 18.   Suboptimal inhibition of protease activity in human immunodeficiency virus type 1: Effects on virion morphogenesis and RNA maturation
  2. Moore, M. D.; Fu, W.; Soheilian, F.; Nagashima, K.; Ptak, R. G.; Pathak, V. K.; Hu, W. S.
  3. Virology. 2008 379(1): 152-160.
  1. 19.   Identification of two distinct human immunodeficiency virus type 1 Vif determinants critical for interactions with human APOBEC3G and APOBEC3F
  2. Russell, R. A.; Pathak, V. K.
  3. Journal of Virology. 2007, Aug; 81(15): 8201-8210.
  1. 20.   A monovalent mutant of cyanovirin-N provides insight into the role of multiple interactions with gp120 for antiviral activity
  2. Fromme, R.; Katiliene, Z.; Giomarelli, B.; Bogani, F.; Mc Mahon, J.; Mori, T.; Fromme, P.; Ghirl, a
  3. Biochemistry. 2007, Aug; 46(32): 9199-9207.
  1. 21.   Capsid is an important determinant for functional complementation of murine leukemia virus and spleen necrosis virus Gag proteins
  2. Lee, S. K.; Boyko, V.; Hu, W. S.
  3. Virology. 2007, Apr; 360(2): 388-397.
  1. 22.   HLA-B Bw4 alleles and HIV-1 transmission in heterosexual couples
  2. Welzel, T. M.; Gao, X. J.; Pfeiffer, R. M.; Martin, M. P.; O'Brien, S. J.; Goedert, J. J.; Carrington, M.; O'Brien, T. R.
  3. Aids. 2007, Jan; 21(2): 225-229.
  1. 23.   Mechanical properties of murine leukemia virus particles: Effect of maturation
  2. Kol, N.; Gladnikoff, M.; Barlam, D.; Shneck, R. Z.; Rein, A.; Rousso, I.
  3. Biophysical Journal. 2006, Jul; 91(2): 767-774.
  1. 24.   Distribution and three-dimensional structure of AIDS virus envelope spikes
  2. Zhu, P.; Liu, J.; Bess, J.; Chertova, E.; Lifson, J. D.; Grise, H.; Ofek, G. A.; Taylor, K. A.; Roux, K. H.
  3. Nature. 2006, JUN 15; 441(7095): 847-852.
  1. 25.   Mutant murine leukemia virus Gag proteins lacking proline at the N-terminus of the capsid domain block infectivity in virions containing wild-type Gag
  2. Rulli, S. J.; Muriaux, D.; Nagashima, K.; Mirro, J.; Oshima, M.; Baumann, J. G.; Rein, A.
  3. Virology. 2006, Apr; 347(2): 364-371.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel